OriGene Technologies, Inc.
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
Webinar on Verified Antigen
Verified Antigen Webinar

Browse all lysates


spacer
OriGene in recent publications
Ginger Compound [6]-Shogaol and Its Cysteine-Conjugated Metabolite (M2) Activate Nrf2 in Colon Epithelial Cells in Vitro and in Vivo Chem. Res. Toxicol. Sep 2014 []

Hepatitis C Virus Subverts Liver-Specific miR-122 to Protect the Viral Genome from Exoribonuclease Xrn2 Cell Host Microbe Aug 2014 []

Novel paracrine modulation of Notch-DLL4 signaling by fibulin-3 promotes angiogenesis in high-grade gliomas Cancer Res. Aug 2014 []

Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study Alzheimers Dement Aug 2014 []

View All Citations >>

spacer

37 Lysate belong to family "stem cell relevant signaling - jak/stat signaling pathway"

divider

  Page: 1 of 2 
Direct Download
spacer
SKUAccnSymbolDescriptionShipping
LY400372NM_001003652SMAD2Transient overexpression lysate of SMAD family member 2 (SMAD2), transcript variant 2 5 days
LY400759NM_002051GATA3Transient overexpression lysate of GATA binding protein 3 (GATA3), transcript variant 2 5 days
LY400876NM_002467MYCTransient overexpression lysate of v-myc myelocytomatosis viral oncogene homolog (avian) (MYC) 5 days
LY401100NM_003153STAT6Transient overexpression lysate of signal transducer and activator of transcription 6, interleukin-4 induced (STAT6) 5 days
LY401230NM_003745SOCS1Transient overexpression lysate of suppressor of cytokine signaling 1 (SOCS1) 5 days
LY401487NM_004671PIAS2Transient overexpression lysate of protein inhibitor of activated STAT, 2 (PIAS2), transcript variant beta 5 days
LY401783NM_005901SMAD2Transient overexpression lysate of SMAD family member 2 (SMAD2), transcript variant 1 5 days
LY401784NM_005902SMAD3Transient overexpression lysate of SMAD family member 3 (SMAD3), transcript variant 1 5 days
LY403284NM_053056CCND1Transient overexpression lysate of cyclin D1 (CCND1) 5 days
LY404514NM_201282EGFRTransient overexpression lysate of epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) (EGFR), transcript variant 2 5 days
LY404515NM_201283EGFRTransient overexpression lysate of epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) (EGFR), transcript variant 3 5 days
LY405010NM_198291SRCTransient overexpression lysate of v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) (SRC), transcript variant 2 5 days
LY406651NM_173206PIAS2Transient overexpression lysate of protein inhibitor of activated STAT, 2 (PIAS2), transcript variant alpha 5 days
LY407836NM_145899HMGA1Transient overexpression lysate of high mobility group AT-hook 1 (HMGA1), transcript variant 1 5 days
LY407837NM_145901HMGA1Transient overexpression lysate of high mobility group AT-hook 1 (HMGA1), transcript variant 3 5 days
LY407838NM_145902HMGA1Transient overexpression lysate of high mobility group AT-hook 1 (HMGA1), transcript variant 4 5 days
LY407839NM_145903HMGA1Transient overexpression lysate of high mobility group AT-hook 1 (HMGA1), transcript variant 5 5 days
LY407840NM_145904HMGA1Transient overexpression lysate of high mobility group AT-hook 1 (HMGA1), transcript variant 6 5 days
LY407841NM_145905HMGA1Transient overexpression lysate of high mobility group AT-hook 1 (HMGA1), transcript variant 7 5 days
LY412433NM_020530OSMTransient overexpression lysate of oncostatin M (OSM) 5 days

 

pattern
Inc 5000 Healthcare Company Copyright © 2014 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title